SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+17.19%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$189M
AUM Growth
+$189M
(+15%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
6.75%
Top 10 Holdings %
Top 10 Hldgs %
41.3%
Holding
79
New
19
Increased
18
Reduced
20
Closed
16
Top Buys
| 1 |
Mersana Therapeutics
MRSN
|
$7.32M |
| 2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$7.32M |
| 3 |
Natera
NTRA
|
$7.3M |
| 4 |
Lantheus
LNTH
|
$6.46M |
| 5 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$5.73M |
Top Sells
| 1 |
Zymeworks
ZYME
|
$15.4M |
| 2 |
Prothena Corp
PRTA
|
$7.06M |
| 3 |
AstraZeneca
AZN
|
$6.96M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$3.63M |
| 5 |
Spyre Therapeutics
SYRE
|
$3.42M |
Sector Composition
| 1 | Healthcare | 94.21% |
| 2 | Real Estate | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Surmodics
SRDX
$487M
| $3.01M | 1.59% | 77,283 +33,305 | +76% | +$1.3M |
|
|
MSON
27
DELISTED
Misonix Inc
MSON
| $2.94M | 1.56% | 250,253 +53,952 | +27% | +$633K |
|
|
ITMR
28
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $2.87M | 1.52% | 140,524 | – | – |
|
|
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.76M | 1.46% | 54,089 +5,289 | +11% | +$270K |
|
30
Merck
MRK
$210B
| $2.21M | 1.17% | +26,579 | New | +$2.21M |
|
31
Zynex
ZYXI
$49.7M
| $2.06M | 1.09% | 118,047 -58,494 | -33% | -$1.02M |
|
|
BPMC
32
DELISTED
Blueprint Medicines
BPMC
| $1.9M | 1.01% | +20,454 | New | +$1.9M |
|
|
PRVB
33
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.79M | 0.95% | 139,418 +79,518 | +133% | +$1.02M |
|
34
Protara Therapeutics
TARA
$120M
| $1.68M | 0.89% | +100,000 | New | +$1.68M |
|
|
NVRO
35
DELISTED
NEVRO CORP.
NVRO
| $1.66M | 0.88% | 11,926 -6,874 | -37% | -$957K |
|
36
Rafael Holdings
RFL
$51.6M
| $1.62M | 0.86% | 104,737 | – | – |
|
|
TRIL
37
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.6M | 0.85% | +112,742 | New | +$1.6M |
|
38
Axogen
AXGN
$743M
| $1.57M | 0.83% | 135,111 +54,761 | +68% | +$637K |
|
39
Lyra Therapeutics
LYRA
$11.5M
| $1.24M | 0.66% | 110,670 +50,000 | +82% | +$559K |
|
40
Larimar Therapeutics
LRMR
$310M
| $1.16M | 0.61% | 76,184 +45,014 | +144% | +$683K |
|
|
RVNC
41
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.05M | 0.55% | 41,617 +13,148 | +46% | +$330K |
|
|
PVLA
42
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $1.04M | 0.55% | +500,000 | New | +$1.04M |
|
|
MDNA
43
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| $1.03M | 0.55% | +248,860 | New | +$1.03M |
|
44
Ionis Pharmaceuticals
IONS
$6.8B
| $932K | 0.49% | 19,648 -16,752 | -46% | -$795K |
|
45
STAAR Surgical
STAA
$1.36B
| $868K | 0.46% | 15,346 -5,082 | -25% | -$287K |
|
46
Insulet
PODD
$23.9B
| $859K | 0.46% | 3,632 -368 | -9% | -$87K |
|
47
CRISPR Therapeutics
CRSP
$4.71B
| $853K | 0.45% | 10,200 -7,000 | -41% | -$585K |
|
|
ARNA
48
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $821K | 0.44% | +10,977 | New | +$821K |
|
|
KDMN
49
DELISTED
Kadmon Holdings, Inc.
KDMN
| $787K | 0.42% | 200,841 | – | – |
|
50
Dynavax Technologies
DVAX
$1.19B
| $725K | 0.38% | 167,798 +67,798 | +68% | +$293K |
|